|
Cilostazol: An Option for Ischemic Stroke After ICH?
Medscape HOUSTON, Texas — The antiplatelet agent cilostazol was noninferior to aspirin in preventing vascular events in patients with a recent ischemic stroke and a history of intracerebral hemorrhage (ICH) or multiple microbleeds in the PICASSO trial … |
5
MAR
MAR
0